Impax Asset Management Group plc Has $6.80 Million Position in TriMas Corporation (NASDAQ:TRS)

Impax Asset Management Group plc decreased its stake in TriMas Corporation (NASDAQ:TRS - Free Report) by 29.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 290,000 shares of the industrial products company's stock after selling 120,000 shares during the period. Impax Asset Management Group plc owned 0.71% of TriMas worth $6,795,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. GAMMA Investing LLC lifted its stake in TriMas by 3,802.9% during the first quarter. GAMMA Investing LLC now owns 14,948 shares of the industrial products company's stock worth $350,000 after purchasing an additional 14,565 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in TriMas by 18.5% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 107,806 shares of the industrial products company's stock worth $2,651,000 after purchasing an additional 16,826 shares during the period. Two Sigma Investments LP boosted its holdings in TriMas by 8.2% in the fourth quarter. Two Sigma Investments LP now owns 134,580 shares of the industrial products company's stock worth $3,309,000 after purchasing an additional 10,210 shares during the last quarter. State of Wyoming bought a new stake in shares of TriMas during the 4th quarter valued at $50,000. Finally, Shay Capital LLC purchased a new position in shares of TriMas in the 4th quarter worth $740,000. 99.42% of the stock is currently owned by institutional investors and hedge funds.

TriMas Price Performance

Shares of NASDAQ TRS traded up $0.37 during midday trading on Wednesday, reaching $29.98. 213,926 shares of the company traded hands, compared to its average volume of 359,098. The stock's 50-day simple moving average is $26.51 and its 200-day simple moving average is $24.32. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.49 and a current ratio of 2.82. The firm has a market cap of $1.22 billion, a PE ratio of 38.94 and a beta of 0.63. TriMas Corporation has a 12 month low of $19.33 and a 12 month high of $30.12.

TriMas (NASDAQ:TRS - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The industrial products company reported $0.46 EPS for the quarter, topping analysts' consensus estimates of $0.43 by $0.03. TriMas had a return on equity of 10.54% and a net margin of 3.36%. The company had revenue of $241.67 million for the quarter, compared to analysts' expectations of $235.41 million. During the same quarter last year, the business earned $0.37 earnings per share. TriMas's revenue was up 6.4% on a year-over-year basis. As a group, equities analysts anticipate that TriMas Corporation will post 1.69 earnings per share for the current fiscal year.

TriMas Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, May 13th. Investors of record on Tuesday, May 6th were issued a dividend of $0.04 per share. The ex-dividend date was Tuesday, May 6th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.53%. TriMas's dividend payout ratio is presently 20.78%.

Insider Buying and Selling at TriMas

In related news, Director Adrianne Shapira purchased 4,000 shares of the firm's stock in a transaction on Thursday, June 5th. The stock was acquired at an average price of $25.82 per share, with a total value of $103,280.00. Following the completion of the acquisition, the director owned 8,476 shares in the company, valued at approximately $218,850.32. This represents a 89.37% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Shawn Sedaghat purchased 410,172 shares of the firm's stock in a transaction dated Wednesday, May 21st. The stock was acquired at an average cost of $25.43 per share, for a total transaction of $10,430,673.96. Following the completion of the purchase, the director owned 1,810,821 shares of the company's stock, valued at approximately $46,049,178.03. This represents a 29.28% increase in their position. The disclosure for this purchase can be found here. Insiders have bought 971,649 shares of company stock valued at $24,585,343 over the last 90 days. Corporate insiders own 14.20% of the company's stock.

Analysts Set New Price Targets

TRS has been the topic of several analyst reports. BWS Financial reaffirmed a "buy" rating and set a $40.00 price target on shares of TriMas in a research report on Wednesday, April 30th. Wall Street Zen upgraded shares of TriMas from a "hold" rating to a "buy" rating in a report on Sunday, June 1st.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.